These findings suggest that using the RF classification model, the six DEG biomarkers (VWF, IL1RL1, DENND2B, MMP14, NAAA, and PANK1) can effectively distinguish IBD patients from healthy controls. Here, PANK1 is linked to inflammatory bowel disease.